MLAB latest filing

Recent Insider Trading Activity MESA LABORATORIES INC /CO/ (MLAB) Recent Insider Trading Activity From Our SEC Form 4 Tracker

Ticker Filing Date Company Insider Title Transaction Shares Price Total Value Position Size Change SEC Filing
MLAB 2026-08-17 MESA LABORATORIES INC /CO/ Sullivan John James Director Sell 7,093 $112.80 $800,090.40 28.46% View Filing
MLAB 2026-08-17 MESA LABORATORIES INC /CO/ Kadia Siddhartha President and CEO Buy 7,093 $112.80 $800,090.40 100.00% View Filing
MLAB 2026-08-17 MESA LABORATORIES INC /CO/ Tripeny R Tony Director Buy 900 $113.69 $102,321.00 14.29% View Filing
MLAB 2026-06-23 MESA LABORATORIES INC /CO/ Crennen Lyndsey Elizabeth CAO Sell 442 $89.50 $39,559.88 17.95% View Filing
MLAB 2026-06-23 MESA LABORATORIES INC /CO/ Archbold Brian David SVP Operations Sell 2,516 $89.50 $225,187.03 28.29% View Filing

Real-time employee trading alerts from SEC Form 4 filings.

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and direct SEC filing links
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.84 seconds
  • Alert intervals starting from one minute
  • Filter alerts by ticker
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.